The influence of statin medications on prostate-specific antigen levels. - Wikidata - wikimedia - TriplyDB

The influence of statin medications on prostate-specific antigen levels.

The influence of statin medications on prostate-specific antigen levels.

http://www.wikidata.org/entity/Q44840521

about

Statin use and risk of prostate cancer: a meta-analysis of observational studies Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis The importance of LDL and cholesterol metabolism for prostate epithelial cell growth Statin drug use is not associated with prostate cancer risk in men who are regularly screened.5-α reductase inhibitors and prostate cancer prevention: where do we turn now?Statin use and cancer risk: a comprehensive review The transcriptomics of de novo androgen biosynthesis in prostate cancer cells following androgen reduction Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness.Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms.Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004.The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer.Statin medications are associated with a lower probability of having an abnormal screening prostate-specific antigen result.Is statin use associated with prostate cancer aggressiveness?The association between statin use and the diagnosis of prostate cancer in a population based cohort Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes.Statins and prostate cancer: role of cholesterol inhibition vs. prevention of small GTP-binding proteins Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database Prostate kallikrein markers in diagnosis, risk stratification and prognosis.Anti-inflammatory drugs, antioxidants, and prostate cancer prevention.LDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies.A Review on the Clinical Utility of PSA in Cancer Prostate The effect of demographic and clinical factors on the relationship between BMI and PSA levels Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer.The Relationship Between Metformin and Serum Prostate-Specific Antigen Levels Does Statin or ASA Affect Survival When Prostate Cancer Is Treated with External Beam Radiation Therapy?Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy Controversies in using urine samples for Prostate Cancer detection: PSA and PCA3 expression analysis.Dyslipidemia, statins and prostate cancer.Statin use and the risk of biochemical recurrence of prostate cancer after definitive local therapy: a meta-analysis of eight cohort studies.Screening for prostate cancer: an updated review.Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes.Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system.Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.Prostate Cancer and Aspirin Use: Synopsis of the Proposed Molecular Mechanisms Is PSA related to serum cholesterol and does the relationship differ between black and white men?Do MDR1 and SLCO1B1 polymorphisms influence the therapeutic response to atorvastatin? A study on a cohort of Egyptian patients with hypercholesterolemia.Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells.

P2860

Q21133952-880C8772-6CE4-4A2F-80B0-26D83272C890 Q27000727-94E8C6C7-063A-430C-8198-19934A9BADA3 Q28727920-C7C6BEA6-C892-4E96-BDFA-7E40FAABB38B Q33922625-1FBA40D5-EE84-4A60-9EEB-CD2765697C4D Q34020127-517D7EB1-10C8-4E2D-8E4F-F880FBA69083 Q34021312-527B961E-715D-434F-B548-A689C18B2507 Q34127128-1418AAB4-2A6C-4A5C-B718-62468C5B7B98 Q34131771-53DC9D3B-838E-4598-BA63-995267A8C2EC Q34158413-25893658-A839-46EE-B329-14914F017D51 Q34380392-E37F2783-11BE-4E52-8CCF-91C3BDB3B6BB Q34433564-1AFAE833-46A8-471B-B711-415442D39361 Q34590302-71451B27-A5F1-4BFB-A57C-245C344D6CD5 Q34626043-0E121F45-A2CD-4739-A25C-EAA47A644E2F Q34846143-B8E96DFA-8DC2-4E58-A403-706F5560273B Q34976557-41275AC8-5C12-4B61-8CF6-AA261EBA299E Q34977627-4576C851-1CC3-4B14-A6EB-00E61C0DA7A5 Q35186197-C5FA91E2-1E4C-49D9-9A1B-56F355F6E6E6 Q35264079-AC78145B-60C1-4F50-9879-AA6225982D40 Q35282895-613742D7-8157-4925-B33E-37CE88354987 Q35683035-BE0A0B6D-826B-498E-B8A5-7387EEEE677B Q35775751-FBC625FB-B717-4893-94C9-AA24D9F97202 Q35988999-D1CE9B35-CF8D-4E6B-BAEF-8E69A220EA5B Q36084063-63520F31-2EFF-4C42-A52A-2B1BEE4557A2 Q36130279-7ACBCE3D-4435-4B9F-85A8-B9E0F6EBD920 Q37283766-A89E9A52-1545-4621-A174-CB4A1669ADD5 Q37316486-13B49447-4C82-4C20-A006-9AB2714FECE1 Q37650468-5F87BDA3-0875-4989-99C4-5E3456AD5192 Q37664965-393E55B9-CAFD-40CA-B08E-C401A4AA1D3B Q37974776-EED748E5-D4D9-458F-9BCC-B9152AFB28C3 Q38030598-03D4463D-FB8E-4A2E-A60F-B0D3896AD109 Q38047044-C42CC6F4-C37F-4B68-A9F8-A57C84575223 Q38069188-1FAE8D28-0E2F-4C33-ADDA-F4B6D62D6B83 Q38268809-D5E5ABD5-5C3A-4CA7-810D-50508018FBF4 Q38571586-4C237F5B-2C47-4370-BBF3-EB15D671D955 Q38728309-55E7AA21-382E-45B2-B491-38B8A106D53D Q38795318-A2BA8897-D07B-4D98-8645-0B704E66FEF2 Q38854428-BA4ACC9D-B8ED-407B-9627-FCA15D9B2261 Q38968138-3947338C-61B0-4619-9402-48C7F52F1059 Q39448926-5B9C81A8-BE45-4722-8AE1-30D3AA100531 Q39666388-E09DEC6C-09ED-404D-85AB-FD41AE1BCAE4

P2860

The influence of statin medications on prostate-specific antigen levels.

http://www.wikidata.org/entity/Q44840521

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

The influence of statin medications on prostate-specific antigen levels.

@en

The influence of statin medications on prostate-specific antigen levels.

@nl

type

label

The influence of statin medications on prostate-specific antigen levels.

@en

The influence of statin medications on prostate-specific antigen levels.

@nl

prefLabel

The influence of statin medications on prostate-specific antigen levels.

@en

The influence of statin medications on prostate-specific antigen levels.

@nl

P1433

Q44840521-9FD0C215-4F5F-4AFE-ADB4-F4BB81240658

P1476

Q44840521-6A8A0A34-1ED1-4B7A-B443-0C22E854B9FA

P2093

Q44840521-369C6628-DAB7-47E2-AF8D-75F6B301C680

Q44840521-744F2AF6-A8FA-4703-BEAA-574711B87DE2

Q44840521-98F0E781-42D5-480B-A07F-0A5C0C03834D

P2860

Q44840521-0618AC84-C934-4F05-8F4E-C8B3DC6651AE

Q44840521-0AAA53FF-16B3-42B4-B575-F5256CA81E22

Q44840521-0F0B6F27-8212-4934-AA42-95285B777157

Q44840521-1073B061-F87D-4146-983A-8316673E38B6

Q44840521-18631FDC-8019-40C1-92CA-A61D4CE3F252

Q44840521-24BABDC2-21F5-44E6-AEFA-000FA87161FF

Q44840521-2B34FDF0-E40F-46BA-B1FF-A7057353100A

Q44840521-321AD570-8A08-43E7-9B4F-0F1DC44B9BF0

Q44840521-3EE70DD3-E662-478A-8497-3A1AD19E7C02

Q44840521-47F50A97-A469-4593-95A4-1C17F6AE671A

P304

Q44840521-D98730D7-E345-4398-A6D9-B949827D5C60

P31

Q44840521-5BAB45C7-B1D8-4E53-9597-537FE23F928D

P356

Q44840521-72B5FA6E-D992-48B7-83C9-1D9790D2F2E5

P407

Q44840521-5C884057-01F2-4876-A8A0-A79A08880544

P433

Q44840521-83CCBA50-14F5-4CCA-A3C0-A8EFFF28FC12

P478

Q44840521-4E2DEA31-FEC8-4493-9153-C3761D1D33FE

P50

Q44840521-9CBC111A-584B-453B-8FEE-EB0C6240EAA3

P577

Q44840521-A8869FD1-D46B-407E-8349-48B11A150D9E

P5875

Q44840521-3348EB15-BD8D-43E8-B734-436E57811044

P698

Q44840521-054F558D-346C-4CA0-8EC6-EACC69640F53

P356

P1433

Journal of the National Cancer Institute

P1476

The influence of statin medications on prostate-specific antigen levels.

@en

P2093

Elizabeth A Platz

http://www.w3.org/2001/XMLSchema#string

Kenneth C Goldberg

http://www.w3.org/2001/XMLSchema#string

Stephen J Freedland

http://www.w3.org/2001/XMLSchema#string

P2860

Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase

Statins and the risk of colorectal cancer

Screening for prostate cancer: recommendation and rationale

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Statins and prostate cancer risk: a case-control study.

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

Statins and cancer risk: a meta-analysis.

The influence of finasteride on the development of prostate cancer.

Statins and risk of cancer: a systematic review and metaanalysis.

Statins reduce the risk of lung cancer in humans: a large case-control study of US veterans.

P304

1511-1518

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJN362

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Robert James Hamilton

P577

2008-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23425372

http://www.w3.org/2001/XMLSchema#string

P698

18957682

http://www.w3.org/2001/XMLSchema#string